Navigation Links
Apieron Strengthens Senior Leadership With Commercial, Financial Appointments
Date:5/19/2009

MENLO PARK, Calif., May 19 /PRNewswire/ -- Apieron, Inc. (www.apieron.com) significantly strengthened its senior management team with the appointment of Steve Bubrick as Vice President, Sales & Marketing, and Bryan Miller as Vice President, Finance. Both appointments are effective immediately.

Mr. Bubrick has more than 20 years of operational and commercial experience in the consumer medical device industry, mainly in diabetes management. Prior to joining Apieron, Mr. Bubrick was the Vice President of Customer Care & Reimbursement for Bedford, Massachusetts-based Insulet Corp., where he contributed to the company's 170% revenue growth in 2008. Before joining Insulet, Mr. Bubrick was Director, Worldwide Marketing for in-vivo products at Abbott Diabetes Care, which was formed by Abbott's acquisition of TheraSense, at which he was a commercial and R&D director. Prior to TheraSense, Mr. Bubrick held numerous commercial and international roles at LifeScan Inc., a division of Johnson & Johnson. Steve earned his BA at the University of California, Berkeley.

"We see many parallels between the self glucose testing and eNO monitoring markets," said Holly McGarraugh, Apieron CEO. "Steve understands how to grow a start up business like Apieron through great marketing and customer relations. His leadership will play a strategically important role in understanding our markets, serving our customers and driving sales of the Insight eNO System. With Bryan filling a critical financial leadership role, and Steve joining us to focus our commercial efforts, we've significantly increased the depth and experience on the senior management team."

Mr. Miller most recently served as a Principal at Berkshire Financial Management LLC where he handled financial and management consulting and equity management of properties in California, Nevada and Arizona. Prior to that, Mr. Miller was the Senior Director of Finance at eV3, (FoxHollow Technologies, Inc.) the medical device company, where he was responsible for financial planning, forecasting and analysis as well as internal reporting. Mr. Miller has an extensive background in financial leadership roles, having held additional senior positions with Trimble Navigation, Shopping the Globe, Inc. and Sega of America. He earned his MBA at Stanford University Graduate School of Business and his BS at University of California, Los Angeles

About the Insight eNO System

The Insight eNO System has been available for use in the physicians' office since March 2008. The system uses a proprietary biosensor technology to measure exhaled nitric oxide, a well established indicator of asthma severity and steroid responsive airway inflammation. Measuring eNO and determining the level of airway inflammation can help clinicians more closely manage their patients' asthma and therefore more precisely titrate medications, which can lead to fewer asthma exacerbations.

About Apieron Inc.

Apieron Inc. is a private, venture-backed medical device company based in Menlo Park, CA that was formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) for the management of asthma. The Apieron biosensor technology platform utilizes a patented technology that allows for the highly sensitive detection of selected analytes like eNO. Apieron is committed to collaborating with physicians and patients to develop innovative medical solutions to improve quality of life and standards of care.

    Contact:
    Steve DiMattia
    (646) 201-5445


'/>"/>
SOURCE Apieron, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. frog design Strengthens Creative Leadership With New Appointments
2. China YCT International (OTCBB: CYIG) Strengthens Corporate Governance With Establishment of Audit Committee and Appointments of Three New Independent Directors
3. Sparta Systems Strengthens TrackWise(R) Enterprise Class Quality Management Solution with Robust Web Services Capabilities
4. NexBio Completes First-in-Man Clinical Trial With DAS181 (Fludase(R)) and Strengthens Clinical Leadership
5. Pharos Innovations Strengthens Leadership Team, Informatics Program
6. LifeSecure Insurance Company Strengthens National Footprint with Partnership Program Approvals in Six States
7. Globus Medical Strengthens Executive Team with Appointment of CFO
8. Duane Reade Holdings, Inc. Further Strengthens Management Team With Addition of Frank Scorpiniti, SVP, Pharmacy Operations
9. Study strengthens link between tobacco smoke and behavioral problems in boys with asthma
10. Innerscope Research Strengthens Management Team With Three Executive Appointments
11. New evidence strengthens link between cigarette smoke exposure and poor infant health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality ... 40th Anniversary of ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. ... not only to the association, but also to the Health Care Quality and Patient ...
(Date:3/23/2017)... ... March 23, 2017 , ... The founders of Dr. ... as winners of American Dreams & Good Housekeeping Seal Initiative, a nationwide search ... and Good Housekeeping. , Steven Wang, MD ., a renowned dermatologist and ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
(Date:3/23/2017)... Rey, CA (PRWEB) , ... March 23, 2017 ... ... its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance ... optimizes and accelerates the coding audit process for all medical chart types with ...
(Date:3/23/2017)... ... , ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous ... Bonetta Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures ... Rose‘s new book presents actual events in the life of her family, which validate ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
(Date:3/23/2017)... 23, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or ... pharmaceutical company, is pleased to announce that its ... from the U.S. Food and Drug Administration (FDA) ... for tetrabenazine tablets in the 12.5 mg and ... a generic equivalent of the branded product Xenazine ...
(Date:3/23/2017)... , March 23, 2017   Casetabs , the ... native mobile app for the iPhone. With this new ... coordination and communication for physician offices, ambulatory surgery centers ... app offers iPhone users even faster, more reliable access ... it even easier to connect care teams so that ...
Breaking Medicine Technology: